Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AV411 in diabetic neuropathy or complex regional pain syndrome
ACTRN12606000403538Phase 2Recruiting
- Sponsor
- Avigen
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ibudilast in diabetic neuropathy and complex regional pain syndrome (CRPS) (2 arms), sponsored by Avigen. Primary endpoints: Safety and tolerability, Pharmacokinetic profile and 1 more. Started Sep 2006; status: recruiting.
02
Drugs
ibudilast
03
Conditions
diabetic neuropathycomplex regional pain syndrome (CRPS)
Beyond the preview
Go deeper on ACTRN12606000403538.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000403538.